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Abstract
Objective To determine the impact of cervical excision for cervical
intraepithelial neoplasia on fertility and early pregnancy outcomes.
Design Systematic review and meta-analysis of cohort studies.
Data sources Medline and Embase.
Eligibility criteria Studies assessing fertility and early pregnancy
outcomes in women with a history of treatment for cervical intraepithelial
neoplasia versus untreated women. We classified the included studies
according to treatment type and fertility or early pregnancy endpoint.
Analysis Pooled relative risks and 95% confidence intervals using a
random effect model, and interstudy heterogeneity with I2 statistics.
Results 15 studies fulfilled the inclusion criteria and were included. The
meta-analysis did not provide any evidence that treatment for cervical
intraepithelial neoplasia adversely affected the chances of conception.
The overall pregnancy rate was higher for treated women than for
untreated women (four studies; 43% v 38%, pooled relative risk 1.29,
95% confidence interval 1.02 to 1.64), although the heterogeneity
between studies was high (P<0.0001). Pregnancy rates did not differ
between women with an intention to conceive (two studies; 88% v 95%,
0.93, 0.80 to 1.08) and the number requiring more than 12 months to
conceive (three studies, 15% v 9%, 1.45, 0.89 to 2.37). Although the
rates for total miscarriages (10 studies; 4.6% v 2.8%, 1.04, 0.90 to 1.21)
and miscarriage in the first trimester (four studies; 9.8% v 8.4%, 1.16,
0.80 to 1.69) was similar for treated and untreated women, cervical
treatment was associated with a significantly increased risk of miscarriage
in the second trimester. The rate was higher for treated women than for
untreated women (eight studies; 1.6% v 0.4%, 16 558 women; 2.60,
1.45 to 4.67). The number of ectopic pregnancies (1.6% v 0.8%; 1.89,
1.50 to 2.39) and terminations (12.2% v 7.4%; 1.71, 1.31 to 2.22) was
also higher for treated women.
Conclusion There is no evidence suggesting that treatment for cervical
intraepithelial neoplasia adversely affects fertility, although treatment
was associated with a significantly increased risk of miscarriages in the
second trimester. Research should explore mechanisms that may explain
this increase in risk and stratify the impact that treatment may have on
fertility and early pregnancy outcomes by the size of excision and
treatment method used.
Introduction
Cervical screening for the early identification and treatment of
cervical intraepithelial neoplasia has reduced the incidence and
mortality from cervical cancer.1 As the precancerous lesions
and their treatment typically occur in women of reproductive
age, the impact of conisation on the outcomes of subsequent
pregnancies has been an area of active research for the past
decade.
Meta-analyses2 3 and large retrospective linkage studies4 5 suggest
that the excisional methods of treatment (cold knife conisation,
large loop excision of the transformation zone (LLETZ), and
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laser conisation) increase the risk of preterm birth, low birth
weight, premature rupture of membranes, and perinatal mortality
in subsequent pregnancies; cervical intraepithelial neoplasia
itself and other confounders may contribute to that risk.6-8
Although the impact of treatment for cervical precancer on
obstetric sequelae has been extensively described, its effect on
the ability to conceive and early pregnancy outcomes has been
relatively under-reported.9 10 Cervical excision removes part of
the endocervical canal and as a result the mucus-secreting
endocervical glands, which produce secretions facilitating
penetration of the sperm and conception. This has been
suggested to adversely affect the chances of conception.11 The
loss of the normal functional cervical structure and the healing
process in the regenerated crater after excision may also induce
severe stenosis of the cervical os, which may further inhibit
sperm penetration and conception.12
Two previous small case series13 14 with limited numbers of
patients reported that cervical treatment did not adversely affect
the time to conception. A retrospective cohort from Finland of
35 000 women with a follow-up of over 250 000 women years
assessing total pregnancy and live birth rates among treated and
untreated women reported no negative effect from treatment.15
Treated women were more likely to have more pregnancies and
children than the reference population; the pregnancy rates in
women with intention to conceive was not reported.15
Conversely, the assessment of the actual time to conception in
another recent large cohort study from the United States reported
that after conisation women took longer to conceive than
untreated normal women or women attending colposcopy but
not treated (time to conception >12 months 16.4% v 8.4%,
adjusted odds ratio 2.09, 95% confidence interval 1.26 to 3.46).16
The impact that treatment may have on conception and child
bearing causes anxiety to women requiring conisation. Although
the impact of treatment on obstetric outcomes has been the
subject of previous reports, there is little evidence on the effect
that this has on the ability to conceive and early pregnancy
outcomes, particularly the rate of miscarriages in the second
trimester. The existing published data are limited, often
contradictory, and poorly documented. In this systematic review
andmeta-analysis we assessed the effect of treatment for cervical
intraepithelial neoplasia on fertility and early pregnancy
outcomes.
Methods
We included all studies that compared fertility and early
pregnancy (<24 weeks’ gestation) outcomes in women with or
without treatment for cervical intraepithelial neoplasia. We also
included all types of treatment, both ablative (laser ablation,
cold coagulation, cryotherapy, or radical diathermy) and
excisional (cold knife conisation, LLETZ—also known as loop
electrosurgical excisional procedure (LEEP), laser conisation,
and needle excision of the transformation zone (NETZ)—also
known as straight wire excision of the transformation zone
(SWETZ)). Studies were included irrespective of the type of
untreated reference population—that is, matched or unmatched
untreated women, internal self matching with the pregnancies
of the same women before treatment, and women attending
colposcopy but not receiving treatment. Studies that reported
on different treatment methods without specifying the exact
type of treatment were also included, even if the outcomes were
not reported separately for each treatment modality. We
excluded studies that did not include an untreated reference
population, compared different treatment techniques without
an untreated control, and compared outcomes for treatments
performed during pregnancy.
Outcome measures
We included outcome measures related to fertility and early
pregnancy outcomes. The fertility outcomes included total
pregnancy rates, pregnancy rates in women wishing to conceive
in an unspecified period, and time to conception. The early
pregnancy outcomes included rates of miscarriage in the first
trimester (<12 weeks’ gestation) and second trimester (between
12 and 24 weeks), and overall (<24 weeks); the rate of ectopic
pregnancies and hydatiform moles; and the rate for termination
of pregnancies.
Retrieval and selection of references
A search of two electronic databases (Medline and Embase)
was conducted targeting reports published between 1960 and
March 2014. There was no language restriction. We used
keywords such as “cervical intraepithelial neoplasia”, “cervical
cancer”, “fertility”, “pregnancy”, “miscarriage”, “conception”,
“LLETZ or LEEP”, “conisation”, “excision”, and “treatment”.
The full search strategy is included in a supplementary file. In
an attempt to identify any articles missed by the initial search
or any unpublished data, we hand searched the references of
the retrieved articles and meta-analyses and the proceedings of
relevant conferences.
Two independent investigators (MK, AM) performed the
literature search, the assessment of eligible reports according
to the inclusion and exclusion criteria, and the extraction of
data. They then compared the results of the search and data
extraction; discrepancies were resolved by consensus, with the
involvement of a third investigator (MA) if necessary.
The Newcastle-Ottawa score was used to formally assess the
quality of the included studies,17 according to the MOOSE
checklist.18
Statistical analysis
From each study we retrieved the number of events in treated
and untreated women for each outcome of interest. We analysed
the data separately for each treatment modality—in groups of
ablative and excisional techniques and as a whole, irrespective
of the method used. We distinguished the different untreated
reference populations across studies (matched to factors in the
treated group, women with cervical intraepithelial neoplasia but
no treatment, self matching or internal controls=before compared
with after treatment). A random effects model was used to pool
the data,19 and Cochrane Revman 5 software to calculate relative
risks and 95% confidence intervals. We used the Cochrane’s Q
test and I2 statistic to assess heterogeneity among studies for
each outcome, corresponding to the percentage of total variance
across studies caused by heterogeneity.20 21We planned to assess
the possible presence of publication bias with funnel plots and
formal testing of small study effects for meta-analyses including
at least 10 studies.22
Results
We identified 167 potentially eligible studies; 15 fulfilled the
inclusion criteria.4 13-16 23-32 No unpublished studies were
identified. All studies were published in English. The details
are presented in the PRISMA flowchart33 together with the
reasons for exclusion (fig 1⇓).
Table 1⇓ shows the characteristics of the included studies and
the outcomes examined. We identified 15 studies assessing
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fertility and early pregnancy outcomes in treated and non-treated
women. Apart from one prospective study,26 the remainder were
described as retrospective cohort studies. There were no
randomised controlled studies. Three studies examined the
impact of cold knife conisation on the studied outcomes,14 24 27
six on large loop excision of the transformation zone
(LLETZ),13 23 25 26 31 32 one on laser conisation,28 and the remaining
five on multiple treatment techniques.4 15 16 29 30 Some studies
adjusted the untreated population for known risk factors for
adverse reproductive outcomes,13 14 23 25 31 some included women
with cervical intraepithelial neoplasia who received no
treatment,32 some did not match for any confounders,26 others
used internal controls (outcomes in the samewomen before and
after treatment),24 27 28 30 whereas some performed a logistic
regression to control for known confounders.4 15 16 29 Two of the
studies using internal controls also matched for known
confounders such as age and parity.27 30 The data were retrieved
from hospital records, questionnaires, and national registries.
The number of participants in the treated and untreated groups
ranged from 21 to 15 108 and from 20 to 2 164 006, respectively
(table 1).
Table 1 shows the Newcastle-Ottawa scores for quality
assessment of the observational studies. All the studies scored
at least 7. A more detailed assessment is included in the
supplementary file.
Table 2⇓ show the fertility and early pregnancy outcomes
assessed in each of the included studies. Tables 3⇓ and 4⇓ show
the pooled results.
Fertility outcomes
The meta-analysis did not provide any evidence to suggest that
treatment for cervical intraepithelial neoplasia adversely affects
the chances of conception (table 3 and fig 2⇓).
The results of the individual studies on the overall pregnancy
rate varied. Two studies did not report any significant
differences,13 32 whereas the remaining two described
significantly higher overall pregnancy rates for the treated
population.13 30 Specifically, one study30 reported that women
treated with laser conisation or ablation had high pregnancy
rates (277/433; 64%) comparedwith untreatedwomen (177/433;
41%) (relative risk 1.56, 95% confidence interval 1.37 to 1.79).
Similarly, another study15 reported higher pregnancy rates for
treated women (multiple methods: cold knife conisation,
LLETZ, laser conisation, laser ablation, cryotherapy) compared
with untreated women (2578/6179; 41.7% v 11642/30463;
38.2%, respectively) (1.09, 1.06 to 1.13). The pooled analysis
for the overall pregnancy rate assessed in four studies was higher
for treated women than for untreated women (43% and 38%)
(1.29, 1.02 to 1.64), although heterogeneity in the studies was
high (P<0.0001, fig 2).
Two small studies assessed the pregnancy rate in women with
an intention to conceive,14 32 and in both the result was no
different between treated and untreated women. The pooled
meta-analysis also confirmed that treated and untreated women
did not differ significantly (two studies; relative risk 0.93, 95%
confidence interval 0.80 to 1.08, fig 3⇓).
Three small studies described the time needed to conceive.13 14 16
Two of them13 14 reported non-significant differences, although
one16 suggested that the proportion of women who required
more than 12 months to conceive was significantly higher for
treated women (all methods, not specified) (25/152; 16%) than
for all untreated women (86/1021; 8.4%) (relative risk 1.95,
95% confidence interval 1.29 to 2.95) or compared with
non-treatedwomen attending for colposcopy (13/151; 9%) (1.91,
1.02 to 3.59). The pooledmeta-analysis suggested that treatment
did not adversely affect the proportion of women who required
more than 12 months to conceive (three studies; 14.7% v 9.2%,
1.45, 0.89 to 2.37, P=0.14, fig 3). The remaining intervals to
conception that were assessed were also not significantly
affected (P>0.05).
Early pregnancy outcomes
Early pregnancy outcomes were assessed in 14 studies. Table
4 and figures 4⇓ and 5⇓ present the results of the meta-analysis
on the early pregnancy outcomes.
All studies reporting on the overall rate for
miscarriage,13-15 24 26-28 31 32 apart from one,30 reported no
significant differences between treated and untreated
populations. One study30 reported a protective effect for treated
women compared with untreated controls (11.4% and 18.6%)
(relative risk 0.60, 95% confidence interval 0.38 to 0.94,
P=0.03). The pooled analysis for the total rate for miscarriage
between treated and untreated women was not significantly
different (10 studies; 4.6% v 2.8%, 1.04, 0.90 to 1.21) for any
of the methods assessed (fig 4).
Four studies reported on miscarriage rates in the first trimester,
separately14 24 27 28; the included studies did not differ
significantly. The pooled meta-analysis for miscarriage rates in
the first trimester showed no significant differences (9.8%
v8.4%; 1.16, 0.80 to 1.69) (fig 5).
Eight studies reported on miscarriage rates in the second
trimester.4 14 23-25 27-29 Seven did not report significant differences,
whereas one with a large sample size4 showed that treated
women had a significantly higher rate of miscarriage in the
second trimester (226/15 108; 1.5%) when compared with
untreated (8501/2 164 006; 0.4%, 3.81, 3.34 to 4.34) or internal
controls (209/57136; 0.4%, 4.09, 3.39 to 4.93). In the pooled
meta-analysis, we found that cervical treatment significantly
increased the risk of miscarriage in the second trimester. This
outcome was assessed in eight studies and 16 558 treated
women. The rate was higher for treated than for untreated
women (1.6% and 0.4%, 2.60, 1.45 to 4.67, fig 5). There was
no significant interstudy heterogeneity.
The rate of ectopic pregnancy was also higher for treated than
for untreated women (1.6% and 0.8%) (six studies, 1.89, 1.50
to 2.39), whereas the rate for molar pregnancy did not differ
(P>0.05). The termination of pregnancy rate was higher in
women with a history of treatment than in untreated controls
(12.2% and 7.4%) (seven studies, 1.71, 1.31 to 2.22).
Given the low number of studies included in each of the
meta-analyses, the risk of publication bias and the potential
sources of heterogeneity could not be assessed formally.
Discussion
Cervical treatment has been associated with an increased risk
of adverse obstetric sequelae and preterm birth in subsequent
pregnancies.2 3 7 34 More recent data suggest that cervical
intraepithelial neoplasia itself may partly contribute to that risk,6
while there seems to be a “dose-response” effect documented
for treatment; the larger the excision or proportion of cervix
removed, the larger and more serious the effect may be from
treatment.5 7 35-38
It has been suggested that cervical treatment may impair future
fertility for women as a result of cervical stenosis and the
reduction of cervical glands and mucus.10 11 Similarly, concerns
have been raised that the rate of miscarriages in the second
trimester is also increased in treated populations. To date, the
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impact on fertility and early pregnancy outcomes has not been
systematically assessed in the published literature.
This systematic review and meta-analysis demonstrates that
there is no evidence to support that treatment for cervical
precancer adversely affects fertility outcomes and the chances
to conceive. Although the pregnancy rate in women with an
intention to conceive was no different, the overall pregnancy
rate was higher for women who received treatment than for
untreated controls; the heterogeneity across studies was
significant. The higher pregnancy rate in the treated population
may be explained by sexual and behavioural characteristics in
women with cervical precancer or their increased anxiety for
their future fertility after treatment. The time required to
conceive was overall similar among the compared populations.
There was a trend towards longer conception time for treated
women, but the differences were not significant. Although this
may hint at an impact of treatment on fertility, it may also be
explained by clinicians’ recommendation to avoid conception
during the early postoperative period and until the first follow-up
assessment confirms the absence of residual disease.
Although the rates for miscarriage overall and in the first
trimester did not differ, this meta-analysis suggests that
treatment for cervical intraepithelial neoplasia increases the risk
of miscarriage in the second trimester, possibly as a result of
cervical incompetence after proportionally large excisions. The
incidence of miscarriages in the second trimester is low and
therefore individual small cohorts often failed to reach
significant results previously. This is the first meta-analysis
combining multiple studies to show statistically significant
differences. Although the results of the analysis are dominated
by one large study,4 this is not an outlier, and exclusion of this
study from the analysis yielded similar results. This study
included various treatment modalities (knife, laser, and LLETZ)
and the outcomes for each individual technique were not
available from the registry linkage. Most deliveries (87%) were
after the 1990s and the introduction of LLETZ, although the
timing of treatment was unclear. The higher number of ectopic
pregnancies and terminations in the treated population possibly
reflects the characteristics of women with cervical precancer,
who are known to be at a higher risk of sexually transmitted
disease and unplanned pregnancies and not related to cervical
intraepithelial neoplasia treatment. It may also be that a
dysfunction in the immune defences and the protective
mechanisms makes some women more prone to ascending
infections and also persistence of human papillomavirus and
cervical precancer. Conversely, human papillomavirus infection
itself may have an effect on antimicrobials in the cervical mucus.
Strengths and limitations of this review
This is the first systematic review to show that fertility is
probably not impaired after treatment. The results, however,
should be interpreted with caution. The included studies were
heterogeneous for study design, included populations, matching
for confounders, length of follow-up, and outcome verification.
The number of studies and the study size were often small for
many of the reported outcomes and the outcomes of interest
were difficult to objectively measure. Although the interstudy
heterogeneity was not significant for all outcomes apart from
one, the number of studies was small and the analysis could be
affected by the addition of further studies. The effect was not
significantly changed by sensitivity analysis excluding some of
the largest studies. All studies apart from one26 described
retrospective cohorts and are prone to possible bias. The data
were derived from self reporting, clinic datasets, telephone
contacts, and postal questionnaires or national registries and
may represent incomplete and selected data. Early pregnancy
outcomes are often less well reported than outcomes in the third
trimester. The level of over-reporting or under-reporting may
be different for treated and untreated women and the impact of
this is difficult to assess. Reporting may be better in the treated
group owing to easier access to gynaecological services or,
conversely, may be lower in womenwith cervical intraepithelial
neoplasia, who often belong to lower socioeconomic classes
that are likely to be less compliant with recommended medical
care. Studies that assess fertility outcomes post-treatment are
difficult owing to the multifactorial nature of the condition (for
example, male, lifestyle). It is often difficult to design such a
study and yet eliminate all of the confounding variables.
The analysis included studies with different designs, using
comparisons between and among women and mixed matching.
It was not possible to carry out subgroup analyses for the
different comparison groups because of the limited number of
studies in each group. It is unlikely that the use of different
comparison groups generated bias because the studies using
different comparators showed similar direction and magnitude
of effect. Four studies used comparisons of the same women
before and after treatment; two of these also matched for known
confounders. A sensitivity analysis that excluded the four studies
using internal comparators and a sensitivity analysis that
excluded old or poor quality studies did not significantly change
the direction or the magnitude of the effect of the meta-analysis.
A separate analysis for different treatment modalities was done,
but the power to identify significant findings was limited owing
to the lack of large studies. An analysis that would stratify
according to the depth of the cone or parity was also not feasible,
as these data were not reported by the individual studies. It is
likely that the risk increases with greater proportions of the
cervix removed. Future studies should try to stratify the risk of
miscarriages in the second trimester and the chances of
conception according to the depth and proportion of cervix
excised. Inability to adjust for size of excision and treatment
technique may mask the true effect that deep conisations could
have on fertility and, conversely, the lack of effect that small
excisions (<10 mm) may have on the risk of miscarriages in the
second trimester.
Possible mechanisms
The exact mechanism that explains the increased risk of
miscarriages in the second trimester and preterm birth associated
with cervical intraepithelial neoplasia and its treatment is
unclear. Although most obstetricians would think that this
increase in risk is due to a simple lack of mechanical support,
histological changes in the healed cervix affecting the tensile
strength39 or changes in the innate immune system and the
vaginal microenvironment probably also make an important
contribution. The uterus in pregnancy is protected from
ascending infection by the cervix, its mucous plug, and its
synthesis of antibacterial compounds, and by a “benign”
lactobacillus dominated vaginal microflora.40 There is a clear
link between infection or inflammation and preterm birth.
Removing part of the cervix or simply being infected with
human papillomavirus may impair the host’s defense
mechanisms and change the chemical microenvironment and
as a result affect the vaginal microbiome or the production of
natural antimicrobials by the cervix.41 It may also be that some
women share immunological variations and other factors that
co-associate with both cervical intraepithelial neoplasia and
preterm birth and that make them susceptible to not only
persistent infections with human papillomavirus but also
ascending infections and preterm birth when pregnant. A better
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understanding of these factors may enable selection of women
at risk and prevention with cause directed strategies.42-46 It may
be possible to manipulate the vaginal microbiota through
microbiome gene regulations and probiotic and prebiotic
treatments to establish a healthy environment, combat disease,
and improve health.42 43
Conclusion and policy implications
Despite the limitations of this meta-analysis, we found no
evidence to suggest that fertility is affected by treatment for
cervical intraepithelial neoplasia, although the risk of
miscarriages in the second trimester was significantly increased.
The risk of second trimester miscarriages with less aggressive
treatment, such as LLETZ, particularly for small excisions, or
the risk for reduced fertility in proportionally large conisations,
remains unclear. Future large, well designed studies are required
to carefully explore possible associations between treatment for
cervical intraepithelial neoplasia and subsequent fertility and
early and late pregnancy outcomes, stratifying by the size of
excision and treatment technique. The exact mechanism and
the extent of excision that increase the risk remain unknown.
Caution should prevail when considering treatment in young
women whomay want future pregnancies. Until more evidence
becomes available, it is important to remove as little tissue as
possible, especially in nulliparous women with a small cervix,
without compromising the eradication of the disease. More
sensitive tests such as those for human papillomavirus DNA
should be used to improve the detection of residual or recurrent
lesions after treatment and to minimise the risk of future cancer
in young women.47 Every effort should be made to optimise
both reproductive and oncological outcomes for women
requiring treatment.37 48
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Tables
Table 1| Characteristics of included studies comparing fertility and early pregnancy outcomes with untreated women
Newcastle-Ottawa
score*OutcomesSource of dataUntreatedTreatedProcedureMatching factorsStudy
8Pregnancy rates in women
wishing to conceive;
conceptions within given
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income, race, parity, body
mass index, smoking status,
cervical surgery, case status
LLETZ=large loop excision of the transformation zone.
All study designs were retrospective cohort, except for Frega et al,26 which was a prospective cohort design.
*Score for quality assessment in observational studies: maximum 9, minimum 0 (see supplementary appendix 2).
†Self matching is comparison of pregnancies in same woman before and after treatment.
‡Different number of cases and controls for every outcome in same study.
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Table 2| Reported individual outcomes in included studies assessing fertility and early pregnancy outcomes between treated and untreated
women
Relative risk (95% CI)
No with outcome/No in group (%)
Treatment and fertility outcomes Untreated groupTreated group
Weber et al 197914
n=20n=21Cold knife conisation:
0.95 (0.76 to 1.20)18 (90)18 (86)PRIC
Time to conception (months):
1.06 (0.55 to 2.05)9 (45)10 (48)0-3
1.04 (0.60 to 1.79)11 (55)12 (57)0-6
1.03 (0.66 to 1.59)13 (65)14 (67)0-9
0.95 (0.63 to 1.44)14 (70)14 (67)0-12
0.95 (0.76 to 1.20)18 (90)18 (86)0-24
n=55n=66Miscarriages:
1.67 (0.67 to 4.15)6 (11)12 (18)Total
1.33 (0.46 to 3.84)5 (9)8 (12)First trimester
3.33 (0.38 to 28.96)1 (2)4 (6)Second trimester
4.17 (0.50 to 34.61)1 (2)5 (8)Termination of pregnancy
Buller et al 198224
n=106n=88Cold knife conisation:
Miscarriages:
1.20 (0.53 to 2.76)10 (9)11 (12.5)Total
1.36 (0.55 to 3.36)8 (7.5)9 (10)First trimester
0.60 (0.06 to 6.53)2 (2)1 (1)Second trimester
3.61 (0.38 to 34.13)1 (1)3 (3)Ectopic pregnancy
0.4 (0.02 to 9.88)1 (1)0 (0)Molar pregnancy
1.93 (1.08 to 3.44)15 (14)24 (27)Termination of pregnancy
Larsson et al 198227
n=341n=294Cold knife conisation:
Miscarriages:
1.25 (0.82 to 1.91)37 (11)40 (14)Total
1.11 (0.65 to 1.91)25 (7)24 (8)First trimester
1.55 (0.74 to 3.22)12 (3.5)16 (5)Second trimester
11.60 (1.49 to 90.07)1 (0.3)10 (3)Ectopic pregnancy
2.87 (1.72 to 4.78)19 (6)47 (16)Termination of pregnancy
Blomfield et al 199323
LLETZ:
4.00 (0.37 to 42.80)1/80 (1)2/40 (5)Second trimester miscarriages
Bigrigg et al 199413
LLETZ:
1.15 (0.88 to 1.51)66/229 (29)76/229 (33)Pregnancy rates
n=62n=72Time to conception (months):
0.86 (0.63 to 1.18)36 (58)36 (50)0-3
1.03 (0.89 to 1.19)51 (82)61 (86)0-6
1.05 (0.94 to 1.17)55 (89)67 (93)0-12
0.50 (0.21 to 1.20)12 (20)7 (10)>12
0.69 (0.19 to 2.45)5 (8)4 (5.5)>36
0.72 (0.23 to 2.26)6/66 (9)5/76 (7)Total miscarriages
0.87 (0.13 to 6.00)2/66 (3)2/76 (3)Ectopic pregnancy
Cruickshank et al 199525
LLETZ:
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Table 2 (continued)
Relative risk (95% CI)
No with outcome/No in group (%)
Treatment and fertility outcomes Untreated groupTreated group
1.33 (0.23 to 7.89)3/298 (1)2/149 (1)Second trimester miscarriages
Sagot et al 199528
Laser conisation:
n=82n=71Miscarriages:
1.05 (0.47 to 2.33)11 (13)10 (14)Total
1.05 (0.47 to 2.33)11 (13)10 (14)First trimester
NE0 (0)0 (0)Second trimester
1.15 (0.17 to 7.99)2 (2)2 (3)Ectopic pregnancy
0.69 (0.27 to 1.81)10 (12)6 (8.5)Termination of pregnancy
Spitzer et al 199530
Laser conisation, laser ablation:
Pregnancy rate:
2.39 (1.70 to 3.37)28/100 (28)67/100 (67)Laser conisation
1.41 (1.22 to 1.63)149/333 (45)210/333 (63)Laser ablation
1.56 (1.37 to 1.79)177/433 (41)277/433 (64)All laser
Total miscarriages:
0.42 (0.16 to 1.08)7/28 (25)7/67 (10)Laser conisation
0.65 (0.39 to 1.09)26/149 (17)24/210 (11)Laser ablation
0.60 (0.38 to 0.94)33/177 (19)31/277 (11)All laser
Ectopic pregnancy:
0.63 (0.11 to 3.55)2/28 (7)3/67 (4.5)Laser conisation
1.77 (0.35 to 9.02)2/149 (1)5/210 (2)Laser ablation
1.28 (0.39 to 4.18)4/177 (2)8/277 (3)All laser
Termination of pregnancy:
2.40 (0.91 to 6.31)4/28 (14)23/67 (34)Laser conisation
1.54 (0.99 to 2.38)24/149 (16)52/210 (25)Laser ablation
1.71 (1.16 to 2.53)28/177 (16)75/277 (27)All Laser
Turlington et al 199632
LLETZ:
0.75 (0.44 to 1.30)21/57 (37)15/54 (28)Pregnancy rate
0.95 (0.76 to 1.20)17/17 (100)11/12 (92)PRIC
0.20 (0.01 to 3.54)3/21 (14)0/15 (0)Total miscarriages
0.28 (0.01 to 5.35)2/21 (9.5)0/15 (0)Termination of pregnancy
Tan et al 200431
LLETZ
1.27 (0.60 to 2.69)11/119 (9)14/119 (12)Total miscarriages
Sjoberg et al 200729
laser conisation, LLETZ
15.00 (0.86 to 262.16)0/742 (0)7/742 (1)Second trimester miscarriages
Albrechtsen et al 20084
Cold knife conisation, laser conisation, LLETZ:
3.81 (3.34 to 4.34) (untreated)8501/2 164 006 (0.4) (untreated)226/15 108 (1.5)Second trimester miscarriages
4.09 (3.39 to 4.93) (internal)209/57136 (0.4) (internal)226/15 108 (1.5)Second trimester miscarriages
Kalliala et al 201215
n=30 463n=6179All treatments*:
1.09 (1.06 to 1.13)11 642 (38)2578 (42)Pregnancy rate
1.11 (0.93 to 1.31)707 (2)159 (3)Total miscarriages
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Table 2 (continued)
Relative risk (95% CI)
No with outcome/No in group (%)
Treatment and fertility outcomes Untreated groupTreated group
1.91 (1.50 to 2.44)229 (1)89 (1)Ectopic pregnancy
1.10 (0.81 to 1.49)225 (1)50 (1)Molar pregnancy
1.52 (1.41 to 1.65)2245 (7)695 (11)Termination of pregnancy
Frega et al 201326
LLETZ:
1.03 (0.75 to 1.42)62/441 (14)69/475 (14.5)Total miscarriages
Spracklen et al 201316
All treatments*:
Time to conception (months):
1.95 (1.29 to 2.95)Untreated 86/1021 (8)25/152 (16)>12
1.91 (1.02 to 3.59)Colposcopy only 13/151 (9)25/152 (16)>12
All treatments*†:
1.97 (1.16 to 3.36)51/611 (8)15/91 (16.5)All excisional
1.92 (1.00 to 3.68)35/410 (8.5)10/61 (16)All ablative
2.15 (1.03 to 4.47)25/302 (8)8/45 (18)LLETZ
1.81 (0.83 to 3.93)26/309 (8)7/46 (15)Cold knife conisation
1.61 (0.70 to 3.70)25/295 (8.5)6/44 (14)Cryotherapy
2.71 (0.95 to 7.67)10/115 (9)4/17 (23.5)Laser ablation
LLETZ=large loop excision of the transformation zone; NA=not available; NE=not estimable; NPIC=number of pregnancies in women with intention to conceive;
PRIC=pregnancy rates in women with an intention to conceive.
*LLETZ, cold knife conisation, cryotherapy, laser conisation, and laser ablation.
†Compared with untreated women.
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treatment Untreated groupTreated group
Total pregnancy rate
0.18 (45)1.00 (0.67 to 1.48)87/286 (30.4)91/283 (32.2)5692No treatmentLLETZ
NE (NE)2.39 (1.70 to 3.37)28/100 (28.0)67/100 (67.0)2001No treatmentLaser conisation
NE (NE)1.41 (1.22 to 1.63)149/333 (44.7)210/333 (63.0)6661No treatmentLaser ablation
NE (NE)1.09 (1.02 to 1.64)11 642/30 436 (38.3)2578/6179 (41.7)36 6151No treatmentTreatment NS
<0.0001 (88)1.29 (1.02 to 1.64)11 906/31 155 (38.2)2946/6895 (42.7)38 0504No treatmentAll treatment types
Pregnancy rate in women with intention to conceive
0.77 (0)0.93 (0.80 to 1.08)35/37 (94.6)29/33 (87.9)702No treatmentAll treatment types
Time to conception
(months):
0.58 (0)0.89 (0.67 to 1.19)45/82 (54.9)46/93 (49.5)1752No treatment0-3
0.97 (0)1.03 (0.89 to 1.19)62/82 (75.6)73/93(78.5)1752No treatment0-6
NE (NE)1.03 (0.66 to 1.59)13/20 (65.0)14/21 (66.7)411No treatment0-9
0.62 (0)1.04 (0.94 to 1.16)69/82 (84.1)81/93 (87.1)1752No treatment0-12
NE (NE)0.95 (0.76 to 1.20)18/20 (90.0)18/21 (85.7)411No treatment0-24
Conception >12 months:
0.39 (0)1.51 (0.78 to 2.92)30/329 (9.1)11/67 (16.4)3962No treatmentCold knife conisation
0.01 (84)1.06 (0.25 to 4.47)37/364 10.2)15/117 (12.8)4812No treatmentLLETZ
NE (NE)2.71 (0.95 to 7.67)10/115 (8.7)4/17 (23.5)1321No treatmentLaser ablation
NE (NE)1.61 (0.70 to 3.70)25/295 (8.5)6/44 (13.6)3391No treatmentCryotherapy
0.03 (73)1.03 (0.40 to 2.65)67/693 (9.7)26/184 (14.1)8773No treatmentExcisional treatment
NE (NE)1.92 (1.00 to 3.68)35/410 (8.5)10/61 (16.4)4711No treatmentAblative treatment
0.10 (46)1.45 (0.89 to 2.37)102/1103 (9.2)36/245 (14.7)13483No treatmentAll treatment types
Conception >12 months:
NE (NE)1.71 (0.54 to 5.45)4/45 (8.9)7/46 (15.2)911Colposcopy onlyCold knife conisation
NE (NE)2.00 (0.65 to 6.17)4/45 (8.9)8/45 (17.8)901Colposcopy onlyLLETZ
NE (NE)4.00 (0.50 to 32.20)1/17 (5.9)4/17 (23.5)341Colposcopy onlyLaser ablation
NE (NE)1.50 (0.45 to 4.95)4/44 (9.1)6/44 (13.6)881Colposcopy onlyCryotherapy
NE (NE)1.85 (0.83 to 4.16)8/90 (8.9)15/91 (16.5)1811Colposcopy onlyExcisional treatment
NE (NE)2.00 (0.73 to 5.51)5/61 (8.2)10/61 (16.4)1221Colposcopy onlyAblative treatment
0.88 (0)1.88 (0.99 to 3.55)13/151 (8.6)25/152 (16.4)3031Colposcopy onlyAll treatment types
Conception >36 months:
NE (NE)0.69 (0.19 to 2.45)5/62 (8.0)4/72 (5.5)1341No treatmentAll treatment types
LLETZ=Large Loop Excision of the Transformation Zone; NS=not specified; NE=not estimable.
Not all abbreviations mentioned NE to termination of pregnancy.
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Effect estimate relative risk
(95% CI)





Early pregnancy outcomes by
treatment group Untreated groupTreated group
Miscarriage rates
Total miscarriages:
0.84 (0)1.30 (0.92 to 1.83)53/502 (10.6)62/448 (13.8)9503Cold knife conisation
0.58 (0)1.03 (0.77 to 1.36)82/647 (12.7)88/685 (12.8)13324LLETZ
0.14 (53)0.69 (0.28 to 1.69)18/110 (16.4)17/138 (12.3)2482Laser conisation
NE (NE)0.65 (0.39 to 1.09)26/149 (17.4)24/210 (11.4)3591Laser ablation
0.50 (0)1.07 (0.87 to 1.31)153/1259 (12.2)167/1271 (13.1)25309Excisional treatment
NE (NE)0.65 (0.39 to 1.09)26/149 (17.4)24/210 (11.4)3591Ablative treatment
NE (NE)1.11 (0.93 to 1.31)707/30 436 (2.3)159/6179 (2.6)36 6151Treatment NS
0.36 (9)1.04 (0.90 to 1.21)886/31 844 (2.8)350/7660 (4.6)39 50410All treatment types
First trimester miscarriages:
0.91 (0)1.20 (0.78 to 1.83)38/502 (7.6)41/448 (9.2)9503Cold knife conisation
NE (NE)1.05 (0.47 to 2.33)11/82 (13.4)10/71 (14.1)1531Laser conisation
0.97 (0)1.16 (0.80 to 1.69)49/584 (8.4)51/519 (9.8)11034Excisional treatment
Second trimester miscarriages:
0.58 (0)1.55 (0.79 to 3.01)15/502 (3.0)21/448 (4.7)9503Cold knife conisation
0.47 (0)1.98 (0.48 to 8.21)4/378 (1.1)4/189 (2.1)5672LLETZ
NE (NE)NE0/82 (0)0/71 (0)1531Laser conisation
0.34 (0)3.82 (3.35 to 4.35)8510/2 164 748 (0.4)233/15 850 (1.5)2 180 5982Excisional treatment NS
0.12 (41)2.60 (1.45 to 4.67)8520/2 165 710 (0.4)258/16 558 (1.6)2 182 2688Excisional treatment
Ectopic pregnancy
0.44 (0)6.83 (1.50 to 31.02)2/447 (0.4)13/282 (3.4)3882Cold knife conisation
NE (NE)0.87 (0.13 to 6.00)2/66 (3.0)2/76 (2.6)1421LLETZ
0.64 (0)0.82 (0.23 to 2.99)4/110 (3.6)5/138 (3.6)2482Laser conisation
NE (NE)1.77 (0.35 to 9.02)2/149 (1.3)5/210 (2.4)3591Laser ablation
0.19 (35)1.77 (0.59 to 5.27)8/623 (1.3)20/596 (3.4)12195Excisional treatment
NE (NE)1.77 (0.35 to 9.02)2/149 (1.3)5/210 (2.4)3591Ablative treatment
NE (NE)1.91 (1.50 to 2.44)229/30 436 (0.8)89/6179 (1.4)366151Treatment NS
0.44 (0)1.89 (1.50 to 2.39)239/31 208 (0.8)114/6985 (1.6)381936All treatment types
Molar pregnancy
NE (NE)0.40 (0.02 to 9.88)1/106 (0.9)0/88 (0)1941Cold knife conisation
NE (NE)1.10 (0.81 to 1.49)225/30 436 (0.7)50/6179 (0.8)36 6151Treatment NS
0.54 (0)1.08 (0.80 to 1.47)226/30 542 (0.7)50/6267 (0.8)36 8092All treatment types
Termination of pregnancy
0.53 (0)2.45 (1.68 to 3.58)35/502 (7.0)76/448 (17.0)9503Cold knife conisation
NE (NE)0.28 (0.01 to 5.35)2/21 (9.5)0/15 (0)361LLETZ
0.07 (69)1.29 (0.38 to 4.37)14/110 (12.7)29/138 (21.0)2482Laser conisation
0.11 (44)1.87 (1.12 to 3.11)51/633 (8.1)105/601 (17.5)12346Excisional treatment
NE (NE)1.54 (0.99 to 2.38)24/149 (16.1)52/210 (24.8)3591Laser ablation
NE (NE)1.54 (0.99 to 2.38)24/149 (16.1)52/210 (24.8)3591Ablative treatment
NE (NE)1.52 (1.41 to 1.65)2245/30 436 (7.4)695/6179 (11.2)36 6151Treatment NS
0.10 (41)1.71 (1.31 to 2.22)2320/31 218 (7.4)852/6990 (12.2)38 2087All treatment types
LLETZ=large loop excision of the transformation zone; NS=not specified; NE=not estimable.
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Figures
Fig 1 PRISMA flowchart
Fig 2 Meta-analysis on overall pregnancy rates in treated versus untreated women. LLETZ=large loop excision of the
transformation zone; LEEP=loop electrosurgical excisional procedure
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Fig 3 Meta-analysis on pregnancy rates in women with an intention to conceive, and time to conception greater than 12
months in treated versus untreated women. CKC=cold knife conisation; LLETZ=large loop excision of the transformation
zone; LEEP=loop electrosurgical excisional procedure
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Fig 4 Forest plots from meta-analysis on rates for total miscarriage in treated versus untreated women. CKC=cold knife
conisation; LLETZ=large loop excision of the transformation zone; LEEP=loop electrosurgical excisional procedure
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Fig 5 Forest plots from the meta-analysis on rates for miscarriage in first and second trimesters in treated versus untreated
women. CKC=cold knife conisation; LLETZ=large loop excision of the transformation zone; LEEP=loop electrosurgical
excisional procedure
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